e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Acute lung injury: hitting the barriers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Stimulation of pp60
Src
activity limits nitric oxide signaling through increases in asymmetric dimethylarginine
S. Black, C. Gross, S. Aggarwal, R. Rafikov, J. Catravas, M. L. Meadows, M. Shaw, S. Kumar (Augusta, Norfolk, United States Of America)
Source:
International Congress 2014 – Acute lung injury: hitting the barriers
Session:
Acute lung injury: hitting the barriers
Session type:
Oral Presentation
Number:
3431
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Black, C. Gross, S. Aggarwal, R. Rafikov, J. Catravas, M. L. Meadows, M. Shaw, S. Kumar (Augusta, Norfolk, United States Of America). Stimulation of pp60
Src
activity limits nitric oxide signaling through increases in asymmetric dimethylarginine. Eur Respir J 2014; 44: Suppl. 58, 3431
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Acute respiratory distress syndrome
Antibiotic prescription patterns for treating respiratory infections across intensive care unit (ICUs) in India
Related content which might interest you:
Effects of ceramide pathway inhibition on the inflammatory response in lipopolysacharide-triggered lung injury
Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2015
Essential oils reduced lung inflammation in a model of acute lung injury
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
LATE-BREAKING ABSTRACT: Trasplantation of alveolar type II cells in experimental Acute Lung Injury
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014
Src regulates ventilation-induced epithelial-mesenchymal transition and epithelial apoptosis
Source: International Congress 2014 – Acute lung injury: hitting the barriers
Year: 2014
LATE-BREAKING ABSTRACT: Activation of MTOR in pulmonary epithelium promotes LPS-induced acute lung injury
Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Year: 2016
Effects of S-nitroso-N-acetyl-penicillamine (SNAP) on inflammation, apoptosis and iNOS activity in an experimental model of acute lung injury
Source: International Congress 2015 – Acute critical care: novelties in critical care
Year: 2015
Characterization of ceramide generation kinetics in a lung injury model induced by lipopolysaccharide
Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2015
Lung inflammation was attenuated by sakuranetin treatment in a model of acute lung injury
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
Expression of water and ion channels proteins in acute respiratory distress syndrome from different etiologies
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
LATE-BREAKING ABSTRACT: Influenza A virus infection reduces alveolar fluid clearance by activation of AMPK and subsequent reduction of Na,K-ATPase protein abundance
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
Down-regulation of RIP140 can prevent LPS-induced inflammation and acute lung injury in mice via PPARγ
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
Rapid activation of pulmonary endothelial cells during high stretch ventilation
in vivo
Source: International Congress 2014 – Acute lung injury: hitting the barriers
Year: 2014
Microvesicles derived from alveolar macrophages mediate epithelial activation via a TNF dependant mechanism
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
The role of SIRT1 in LPS-induced lung endothelial barrier dysfunction and lung injury in vivo
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
Obesity is associated with airspace lipid dysregulation
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Obesity modulates the alveolar macrophage response
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
Ventilation-induced neutrophil infiltration depends on nuclear factor-kB and NF-kB repressing factor
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013
Dysfunction of oxidized pulmonary surfactant is cholesterol-dependent
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
The self-protection effect from ischemia reperfusion lung injury in Adenine-induced renal failure rat model
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
The Involvement of NLRX1 in Pulmonary Hyperoxic Acute Injury.
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept